These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19584759)

  • 1. Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?
    Sach TH; Barton GR; Jenkinson C; Doherty M; Avery AJ; Muir KR
    Med Care; 2009 Aug; 47(8):889-94. PubMed ID: 19584759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions.
    Davis JC; Liu-Ambrose T; Khan KM; Robertson MC; Marra CA
    Osteoporos Int; 2012 Jul; 23(7):1849-57. PubMed ID: 21909728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeled cost-effectiveness of transforaminal lumbar interbody fusion compared with posterolateral fusion for spondylolisthesis using N(2)QOD data.
    Carreon LY; Glassman SD; Ghogawala Z; Mummaneni PV; McGirt MJ; Asher AL
    J Neurosurg Spine; 2016 Jun; 24(6):916-21. PubMed ID: 26895529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments.
    Yang F; Devlin N; Luo N
    Eur J Health Econ; 2019 Feb; 20(1):99-105. PubMed ID: 29948432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
    Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
    Adams R; Walsh C; Veale D; Bresnihan B; FitzGerald O; Barry M
    Pharmacoeconomics; 2010; 28(6):477-87. PubMed ID: 20465316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
    Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
    Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain.
    Barton GR; Sach TH; Avery AJ; Doherty M; Jenkinson C; Muir KR
    Cost Eff Resour Alloc; 2009 Jul; 7():12. PubMed ID: 19615052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
    Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
    Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unchained melody: revisiting the estimation of SF-6D values.
    Craig BM
    Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
    Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
    Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
    Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
    Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies.
    Joore M; Brunenberg D; Nelemans P; Wouters E; Kuijpers P; Honig A; Willems D; de Leeuw P; Severens J; Boonen A
    Value Health; 2010; 13(2):222-9. PubMed ID: 19878492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the Performance of 2 Health Utility Measures in the Medicare Health Outcome Survey (HOS).
    Jia H; Lubetkin EI; DeMichele K; Stark DS; Zack MM; Thompson WW
    Med Decis Making; 2018 Nov; 38(8):983-993. PubMed ID: 30403580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD).
    Chen J; Wong CK; McGhee SM; Pang PK; Yu WC
    PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the validity of two indirect utility instruments as measures of postoperative recovery.
    Lee L; Mata J; Augustin BR; Carli F; Morin N; Latimer E; Feldman LS
    J Surg Res; 2014 Jul; 190(1):79-86. PubMed ID: 24629417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
    J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.